Ligand validation:6FRN

7MT: Tb-Xo4

7MT is a Ligand Of Interest in 6FRN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FRN_7MT_D_508	91%	36%	0.104	0.99	1.11	1.42	1	2	0	0	100%	1
6FRN_7MT_D_509	90%	25%	0.105	0.989	1.43	1.64	2	4	0	0	100%	1
6FRN_7MT_C_509	89%	25%	0.111	0.989	1.43	1.64	2	4	0	0	100%	1
6FRN_7MT_C_508	80%	27%	0.133	0.983	1.12	1.81	1	6	0	0	100%	1
6FRM_7MT_A_502	78%	25%	0.14	0.984	1.43	1.64	2	4	0	0	100%	1
6F2J_7MT_A_205	98%	33%	0.074	0.995	1.11	1.51	2	4	0	0	100%	0.85
6F2M_7MT_D_302	95%	21%	0.092	0.995	1.46	1.84	3	7	0	0	100%	0.8
6F2F_7MT_A_201	93%	23%	0.092	0.989	1.25	1.89	3	7	0	0	100%	0.8
6F2I_7MT_A_202	90%	34%	0.105	0.99	1.17	1.41	2	2	0	0	100%	0.85
8BPQ_7MT_A_402	90%	21%	0.107	0.992	1.43	1.9	4	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.